Table 3. Pathways identified by ontological analysis to be over-represented in MSC STAT3C versus MSC AdGFP.
Pathways | Homo sapiens genes | Regulated genes 1.5 fold STAT3C v AdGFP | Expected | P value |
Inflammation mediated by chemokine and cytokine signaling pathway | 283 | 23 | 6.21 | 1.33E−07 |
Angiogenesis | 191 | 12 | 4.19 | 1.27E−03 |
Unclassified | 17337 | 362 | 380.51 | 6.54E−03 |
Plasminogen activating cascade | 18 | 3 | 0.4 | 7.63E−03 |
Insulin/IGF pathway-mitogen activated protein kinase kinase/MAP kinase cascade | 35 | 4 | 0.77 | 7.84E−03 |
Interleukin signaling pathway | 161 | 9 | 3.53 | 1.01E−02 |
Oxidative stress response | 60 | 5 | 1.32 | 1.11E−02 |
Alzheimer disease-presenilin pathway | 122 | 7 | 2.68 | 1.94E−02 |
Blood coagulation | 48 | 4 | 1.05 | 2.23E−02 |
Cytoskeletal regulation by Rho GTPase | 98 | 6 | 2.15 | 2.23E−02 |
Interferon-gamma signaling pathway | 29 | 3 | 0.64 | 2.68E−02 |
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | 134 | 7 | 2.94 | 3.01E−02 |
Ras Pathway | 79 | 5 | 1.73 | 3.15E−02 |
TGF-beta signaling pathway | 145 | 7 | 3.18 | 4.29E−02 |
Threonine biosynthesis | 2 | 1 | 0.04 | 4.29E−02 |
Lysine biosynthesis | 2 | 1 | 0.04 | 4.29E−02 |
Carnitine metabolism | 2 | 1 | 0.04 | 4.29E−02 |
Carnitine and CoA metabolism | 2 | 1 | 0.04 | 4.29E−02 |
FAS signaling pathway | 36 | 3 | 0.79 | 4.59E−02 |
Toll receptor signaling pathway | 62 | 4 | 1.36 | 4.91E−02 |
Pathways identified by ontological analysis to be significantly overrepresented in the differentially regulated genes of the STAT3C MSCs versus AdGFP MSCs analysis.